Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Outcome of Allogeneic HSCT after Chemo-Based Conditioning in Infants with Acute Myeloid Leukemia in First Complete Remission: A Multicenter EBMT-PDWP Study

Blood (2021) 138 (Supplement 1): 2862.

https://doi.org/10.1182/blood-2021-145858

Published: 2021

Journal Articles

Stem Cell Transplantation for Pediatric Patients with Non-Anaplastic Peripheral T-Cell Lymphoma on Behalf of the EBMT-Pediatric Diseases Working Party

Olga Moser, MD, Arnaud Dalissier, PhD, Eric Beohou, Wilhelm Woessmann, MD, Birgit Burkhardt, MD PhD, Karin Mellgren, MD PhD, Peter Bader, MD PhD, Andre Manfred Willasch, MD, Udo Kontny, MD

Blood (2018) 132 (Supplement 1): 5787.

https://doi.org/10.1182/blood-2018-99-116809

Published: 2018

Journal Articles

Outcome of Children Developing Grade III-IV Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Report on Behalf of the EBMT Paediatric Diseases Working Party

Alice Bertaina, MD PhD, Franco Locatelli, MD PhD, Anita Lawitschka, Adriana Balduzzi, MD, Jean-Hugues Dalle, MD PhD, Petr Sedlacek, MD, Andre Manfred Willasch, MD, Isaac Yaniv, MD, Christina Peters, MD, Peter Bader, MD PhD

Blood (2017) 130 (Supplement 1): 76.

https://doi.org/10.1182/blood.V130.Suppl_1.76.76

Published: 2017

Journal Articles

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

Andre Manfred Willasch, MD, Christina Peters, MD, Petr Sedlacek, MD, Jean-Hugues Dalle, MD, Stelios Graphakos, MD, Akif Yesilipek, MD, Jacek Wachowiak, Prof MDPhD, Arjan Lankester, MD PhD, Arcangelo Prete, MD, Amir Ali Hamidieh, MD, Marianne Ifversen, Jochen Büchner, MDPhD, Gergely Krivan, MD, Rose-Marie Hamladji, MD, Cristina Diaz de Heredia, MD, Elena Skorobogatova, MD PhD, Gerard Michel, MD, Franco Locatelli, MD PhD, Alice Bertaina, MD PhD, Paul Veys, MD, Sophie Dupont, MD, Reuven Or, MD, Tayfun Guengoer, Olga Aleinikova, MD PhD, Sabina Sufliarska, MD, Mikael Sundin, MD PhD, Jelena Rascon, MD, Ain Kaare, MD, Damir Nemet, MD PhD, Franca Fagioli, MD, Thomas Klingebiel, MD, Jan Styczynski, PhD, Marc B Bierings, MDPhD, Kalman Nagy, MD, Manuel Abecasis, MD, Boris V Afanasyev, MD PhD Professor, Marc Ansari, MD, Arnaud Dalissier, Myriam Labopin, MD, Eric Beohou, Peter Bader, MD PhD

Blood (2017) 130 (Supplement 1): 911.

https://doi.org/10.1182/blood.V130.Suppl_1.911.911

Published: 2017

Journal Articles

Safety and Tolerability of Donor Type Red Blood Cell Transfusion before Allogeneic Stem Cell Transplantation in Children with Major ABO Mismatch

Andrea Jarisch, MD, Jan Soerensen, MD, Emilia Salzmann, Eva Rettinger, MD, Andre Manfred Willasch, MD, Shahrzad Bakhtiar, MD, Rejane Bager, Dieter Klarmann, MD, Thomas Klingebiel, MD, Peter Bader, MD

Blood (2016) 128 (22): 3415.

https://doi.org/10.1182/blood.V128.22.3415.3415

Published: 2016

Journal Articles

Treatment of Iron Overload in Transfusion-Dependent Anemias Post Hematopoietic Stem Cell Transplantation: When to Start? When to Stop?

Andrea Jarisch, MD, Regine Grosse, MD, Emilia Salzmann-Manrique, Roland Fischer, PhD, Jan Soerensen, MD, Renate Hammerstingl, MD, Eva Rettinger, MD, Andre Manfred Willasch, MD, Thomas Klingebiel, MD, Peter Bader, MD

Blood (2015) 126 (23): 3369.

https://doi.org/10.1182/blood.V126.23.3369.3369

Published: 2015

Journal Articles

Repetitive Infusions of Cytokine-Induced Killer (CIK) Cells for Treatment of Impending Relapse in High-Risk Leukemia Patients after Allogeneic Stem Cell Transplantation

Eva Rettinger, MD, Sabine Huenecke, PhD, Verena Pfirrmann, Michael Merker, MD, Andre Manfred Willasch, MD, Andrea Jarisch, MD, Jan Soerensen, MD, Halvard Boenig, Prof., Gesine Bug, MD, Thomas Klingebiel, Prof., Peter Bader

Blood (2014) 124 (21): 2438.

https://doi.org/10.1182/blood.V124.21.2438.2438

Published: 2014

Journal Articles

Long-Term Outcome of Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring after Allogeneic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia: A Single Center Experience

Eva Rettinger, MD, Michael Merker, MD, Hermann Kreyenberg, PhD, Thomas Krenn, MD, Matthias Dürken, MD, Jörg Faber, MD PhD, Sabine Huenecke, PhD, Claudia Brehm, PhD, Melanie Bremm, PhD, Shahrzad Bakhtiar, MD, Andre Manfred Willasch, MD, Andrea Jarisch, MD, Jan Soerensen, MD, Thomas Klingebiel, Prof., Peter Bader

Blood (2014) 124 (21): 3953.

https://doi.org/10.1182/blood.V124.21.3953.3953

Published: 2014

Journal Articles

Clinical Impact Of Post-Transplant Chimerism Monitoring In CD33/34 Bone Marrow Subpopulations and Whole Blood In Pediatric AML: Prospective Comparison Of Highly Sensitive Real Time Sequence Polymorphism PCR Versus Gold-Standard Conventional STR-PCR

Andre Manfred Willasch, MD, Eva Rettinger, MD, Marion Zabel, MD, Hermann Kreyenberg, PhD, Vida Meyer, Arndt Borkhardt, MD, Markus Metzler, MD, Bernhard Kremens, MD, Brigitte Strahm, MD, Wilhelm Woessmann, MD, Christine Mauz-Koerholz, MD, Bernd Gruhn, Stefan Burdach, MD, Michael H Albert, MD, Paul G. Schlegel, MD, Thomas Klingebiel, MD, Peter Bader

Blood (2013) 122 (21): 411.

https://doi.org/10.1182/blood.V122.21.411.411

Published: 2013

NARROW

Outcome of Allogeneic HSCT after Chemo-Based Conditioning in Infants with Acute Myeloid Leukemia in First Complete Remission: A Multicenter EBMT-PDWP Study

Stem Cell Transplantation for Pediatric Patients with Non-Anaplastic Peripheral T-Cell Lymphoma on Behalf of the EBMT-Pediatric Diseases Working Party

Outcome of Children Developing Grade III-IV Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Report on Behalf of the EBMT Paediatric Diseases Working Party

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

Safety and Tolerability of Donor Type Red Blood Cell Transfusion before Allogeneic Stem Cell Transplantation in Children with Major ABO Mismatch

Treatment of Iron Overload in Transfusion-Dependent Anemias Post Hematopoietic Stem Cell Transplantation: When to Start? When to Stop?

Repetitive Infusions of Cytokine-Induced Killer (CIK) Cells for Treatment of Impending Relapse in High-Risk Leukemia Patients after Allogeneic Stem Cell Transplantation

Long-Term Outcome of Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring after Allogeneic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia: A Single Center Experience

Clinical Impact Of Post-Transplant Chimerism Monitoring In CD33/34 Bone Marrow Subpopulations and Whole Blood In Pediatric AML: Prospective Comparison Of Highly Sensitive Real Time Sequence Polymorphism PCR Versus Gold-Standard Conventional STR-PCR

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only